Cargando…

Metastatic and locally aggressive BCC: Current treatment options

The treatment of locally advanced and metastatic BCC presents a significant clinical challenge. Treatment options have evolved recently to include the use of hedgehog inhibitors Vismodigib and Sonidigib and immunotherapy with Cemiplimab.

Detalles Bibliográficos
Autores principales: Casey, Máire‐Caitlín, Pollock, Roisín, Enright, Rachel H, O'Neill, James Paul, Shine, Neville, Sullivan, Paul, Martin, Fiachra T, O'Sullivan, Barry
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517578/
https://www.ncbi.nlm.nih.gov/pubmed/34691462
http://dx.doi.org/10.1002/ccr3.4965
_version_ 1784584050842796032
author Casey, Máire‐Caitlín
Pollock, Roisín
Enright, Rachel H
O'Neill, James Paul
Shine, Neville
Sullivan, Paul
Martin, Fiachra T
O'Sullivan, Barry
author_facet Casey, Máire‐Caitlín
Pollock, Roisín
Enright, Rachel H
O'Neill, James Paul
Shine, Neville
Sullivan, Paul
Martin, Fiachra T
O'Sullivan, Barry
author_sort Casey, Máire‐Caitlín
collection PubMed
description The treatment of locally advanced and metastatic BCC presents a significant clinical challenge. Treatment options have evolved recently to include the use of hedgehog inhibitors Vismodigib and Sonidigib and immunotherapy with Cemiplimab.
format Online
Article
Text
id pubmed-8517578
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-85175782021-10-21 Metastatic and locally aggressive BCC: Current treatment options Casey, Máire‐Caitlín Pollock, Roisín Enright, Rachel H O'Neill, James Paul Shine, Neville Sullivan, Paul Martin, Fiachra T O'Sullivan, Barry Clin Case Rep Case Report The treatment of locally advanced and metastatic BCC presents a significant clinical challenge. Treatment options have evolved recently to include the use of hedgehog inhibitors Vismodigib and Sonidigib and immunotherapy with Cemiplimab. John Wiley and Sons Inc. 2021-10-15 /pmc/articles/PMC8517578/ /pubmed/34691462 http://dx.doi.org/10.1002/ccr3.4965 Text en © 2021 The Authors. Clinical Case Reports published by John Wiley & Sons Ltd. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ (https://creativecommons.org/licenses/by-nc-nd/4.0/) License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Case Report
Casey, Máire‐Caitlín
Pollock, Roisín
Enright, Rachel H
O'Neill, James Paul
Shine, Neville
Sullivan, Paul
Martin, Fiachra T
O'Sullivan, Barry
Metastatic and locally aggressive BCC: Current treatment options
title Metastatic and locally aggressive BCC: Current treatment options
title_full Metastatic and locally aggressive BCC: Current treatment options
title_fullStr Metastatic and locally aggressive BCC: Current treatment options
title_full_unstemmed Metastatic and locally aggressive BCC: Current treatment options
title_short Metastatic and locally aggressive BCC: Current treatment options
title_sort metastatic and locally aggressive bcc: current treatment options
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517578/
https://www.ncbi.nlm.nih.gov/pubmed/34691462
http://dx.doi.org/10.1002/ccr3.4965
work_keys_str_mv AT caseymairecaitlin metastaticandlocallyaggressivebcccurrenttreatmentoptions
AT pollockroisin metastaticandlocallyaggressivebcccurrenttreatmentoptions
AT enrightrachelh metastaticandlocallyaggressivebcccurrenttreatmentoptions
AT oneilljamespaul metastaticandlocallyaggressivebcccurrenttreatmentoptions
AT shineneville metastaticandlocallyaggressivebcccurrenttreatmentoptions
AT sullivanpaul metastaticandlocallyaggressivebcccurrenttreatmentoptions
AT martinfiachrat metastaticandlocallyaggressivebcccurrenttreatmentoptions
AT osullivanbarry metastaticandlocallyaggressivebcccurrenttreatmentoptions